Clinical Trial Update: A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia. [Phase 3]

View source ↗

Summary

Novadip Biosciences is conducting a Phase 3 study to assess the effectiveness and safety of NVD003 for congenital pseudarthrosis of the tibia; the trial is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Pseudarthrosis of Tibia

Drugs mentioned

• NVD003

Snippet

Sponsor: Novadip Biosciences | Conditions: Congenital Pseudarthrosis of Tibia | Phase 3 | Status: RECRUITING